IDYA
Price:
$31.23
Market Cap:
$2.95B
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a (MAT2A) blocking agent, is currently in early-stage (Phase I) trials for solid tumors exhibiting methylthioadenosine phosphorylase (MTAP) deletions. Its second primary candidate, IDE196, a protein kinase C (PKC) inhibitor, is progressing through Phase I/II studies, targeting genetically...[Read more]
Industry
Biotechnology
IPO Date
2019-05-23
Stock Exchange
NASDAQ
Ticker
IDYA
According to IDEAYA Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -13.96%. This represents a change of 253.32% compared to the average of -3.95% of the last 4 quarters.
The mean historical ROE of IDEAYA Biosciences, Inc. over the last ten years is -0.24%. The current -13.96% ROE has changed 5.68% with respect to the historical average. Over the past ten years (40 quarters), IDYA's ROE was at its highest in in the December 2018 quarter at 17.49%. The ROE was at its lowest in in the March 2018 quarter at -55.46%.
Average
-0.24%
Median
-16.78%
Minimum
-41.81%
Maximum
75.37%
Discovering the peaks and valleys of IDEAYA Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 42.49%
Maximum Annual ROE = 75.37%
Minimum Annual Increase = -159.58%
Minimum Annual ROE = -41.81%
| Year | ROE | Change |
|---|---|---|
| 2025 | -11.11% | -57.11% |
| 2024 | -25.91% | 42.49% |
| 2023 | -18.19% | 8.36% |
| 2022 | -16.78% | 1.70% |
| 2021 | -16.50% | -5.14% |
| 2020 | -17.40% | -58.39% |
| 2019 | -41.81% | -159.58% |
| 2018 | 70.17% | -6.90% |
The current ROE of IDEAYA Biosciences, Inc. (IDYA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.41%
5-year avg
-17.70%
10-year avg
-0.24%
IDEAYA Biosciences, Inc.’s ROE is greater than Scholar Rock Holding Corporation (-163.52%), greater than Mineralys Therapeutics, Inc. (-27.92%), greater than Zai Lab Limited (-24.29%), greater than Cidara Therapeutics, Inc. (-60.15%), greater than Beam Therapeutics Inc. (-5.89%), greater than Adaptive Biotechnologies Corporation (-24.26%), greater than Amicus Therapeutics, Inc. (-12.02%), less than Kiniksa Pharmaceuticals, Ltd. (13.26%), greater than Legend Biotech Corporation (-24.91%), greater than Cogent Biosciences, Inc. (-83.29%),
| Company | ROE | Market cap |
|---|---|---|
| -163.52% | $5.67B | |
| -27.92% | $1.63B | |
| -24.29% | $2.04B | |
| -60.15% | $5.61B | |
| -5.89% | $3.51B | |
| -24.26% | $2.81B | |
| -12.02% | $4.55B | |
| 13.26% | $4.14B | |
| -24.91% | $5.17B | |
| -83.29% | $5.90B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IDEAYA Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IDEAYA Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is IDEAYA Biosciences, Inc.'s ROE?
How is the ROE calculated for IDEAYA Biosciences, Inc. (IDYA)?
What is the highest ROE for IDEAYA Biosciences, Inc. (IDYA)?
What is the 3-year average ROE for IDEAYA Biosciences, Inc. (IDYA)?
What is the 5-year average ROE for IDEAYA Biosciences, Inc. (IDYA)?
How does the current ROE for IDEAYA Biosciences, Inc. (IDYA) compare to its historical average?